|Articles|May 12, 2022
Predictive Pooling Strategy: Global Biotech Company Reduces Risk in Downstream Purification
Author(s)Aizon
Read this case study on a large global biotechnology company that was looking to explore predictive models to improve the yield of their downstream bioprocess using historical data.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
EMA Calls New EU Pharma Legislation Most Significant in Two Decades
2
FDA’s CNPV Pilot Gives First Approval to Antibiotic for Pneumonia and Sinusitis
3
European Parliament Revamps Pharmaceutical Policy Framework
4
PharmTech Weekly News Roundup – Week of December 8, 2025
5
